AMCP Foundation recognizes Montrell Taylor, 2021 PharmD Candidate at Howard University College of Pharmacy, for his successful completion of the Genentech Evidence for Access Summer Internship Program.
AMCP Foundation proudly recognizes two student pharmacists who recently completed the Managed Care: Oncology Summer Internship program with the generous support of Pfizer, Inc.’s US Oncology Organized Customer Team.
AMCP Foundation recognizes two student pharmacists from the University of Southern California and University of Washington for the successful completion of the Specialized Summer Internship Program in Health Outcomes, sponsored by AbbVie, Inc.
Today, the Administration released a final rule, Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals, along with an interim final rule, Most Favored Nations (MFN) Model. In response, AMCP CEO Susan A. Cantrell, RPh, CAE, released the following statement.
Supreme Court Hears Oral Arguments in California v. Texas; AMCP Submits Comments on CMS Third COVID Interim Final Rule; AMCP Submits Comments on Medicare Coverage of Innovative Technology Proposed Rule; Pharmaceutical Supply and Payment Chain Coalition Releases Principles for Safe Access to COVID-19 Vaccine; HHS Partners with Pharmacies to Distribute COVID-19 Vaccine; CMS Releases Fourth COVID-19 Interim Final Rule with Comment Period (IFC-4); Trump Administration Releases Insurance Transparency Final Rule; FDA Releases Essential Medicines under ‘Buy American’ Executive Order; Election 2020: A Biden/Harris White House, Slim Democrat House Majority, and Senate Runoff.
AMCP Submits Comments to CMS About the Part D Medication Therapy Management Program; U.S. Supreme Court Hears Arguments in the Rutledge v. Pharmaceutical Care Management Association (PCMA) Case; President Trump’s Plan to Deliver $200 Prescription Drug Discount Cards to Seniors is Delayed; FDA Releases Guidance Regarding COVID-19 Vaccines; FDA Authorizes a Point-of-care Coronavirus Antibody Test; Senate Committee Holds Hearing on Federal Response to COVID-19.